Characterization of White Blood Cells Sub-populations From Multiple Sclerosis Patients.

Characterization and Quantitative Analysis of White Blood Cells in the Blood and Cerebrospinal Fluid of MS Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03486665

Enrollment

Registered

2018-04-03

Start date

2018-04-24

Completion date

2020-03-31

Last updated

2018-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Brief summary

Multiple sclerosis (MS) is a chronic progressive neurological autoimmune disease, that gradually affects patient's quality of life. There are about 2.5 millions patients world wide, with an increasing cost Burdon. Up to date, it remains unclear who are the exact cells to initiate the disease. During the disease, the repertoire of cells expands and undergoes changes. The purpose of this study is to characterize those changes.

Interventions

OTHERBlood Sampling

Blood samples will be taken from all patients and healthy volunteers.

OTHERCSF Sampling

CSF sample will be taken from hospitalized newly diagnosed patients only.

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* Patients with diagnosis of MS according to the revised criteria of McDonald or healthy volunteers * Ability to provide written informed consent.

Exclusion criteria

\- Active malignant disease

Design outcomes

Primary

Measure	Time frame
Quantification of disease related white blood cells from blood and/ or CSF	through study completion, an average of 6 months

Countries

Israel

Contacts

Primary ContactSigalit Carmel, MD, MSc

sigalit@bioimmunate.com+97225649302

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026